- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Alembic Pharmaceuticals urges shareholders to claim unpaid dividends from the past seven years to avoid equity shares being transferred to the Investor Education and Protection Fund. Shareholders holding physical shares should update their KYC and nomination details to prevent share transfer. While this affects dormant shares, it has no immediate financial impact on the company's operations.